6 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated announced today that the Company will present at the 27th Annual J.P.

Morgan Healthcare Conference on Wednesday, January 14, 2009 at 3 p.m.

Pacific time (6 p.m.

6 /PRNewswire/ -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the placement of a next-generation protein analysis system prototype, the Cell...

and SAN DIEGO, Jan.

6 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

and La Jolla Pharmaceutical Company announced today that they have entered into an agreement to develop and commercialize Riquent(R), La Jolla...

6 /PRNewswire/ -- S*BIO Pte Ltd today announced that the...

6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc.

today announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2),...

6 /PRNewswire-FirstCall/ -- Warner Chilcott Limited today announced that it has signed an agreement with Dong-A PharmTech Co.

Ltd., based in Korea, to develop and market their orally-administered udenafil product,...

6 /PRNewswire-FirstCall/ -- InterMune, Inc.

today announced that Daniel G.

Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the 27th Annual J.P.

Morgan Healthcare Conference...

6 /PRNewswire-FirstCall/ -- Medarex, Inc.

announced today that it is scheduled to present at the 27th Annual J.P.

Morgan Healthcare Conference at 8:30 a.m.

Pacific Time (11:30 a.m.

Eastern Time) on Tuesday,...

6 /PRNewswire-FirstCall/ -- Baxter International , will host a quarterly conference call to discuss its fourth quarter 2008 financial results on Thursday, January 22, 2009, at 8:30 a.m.

Eastern Time (7:30 a.m.

6 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc.

today announced that in preparation of further equity offerings, Robert W.

Duggan & Associates ('RWD') made an unsecured loan to Pharmacyclics, Inc.

on...